What contributes to quality of life in patients with Parkinson's disease?

Journal of Neurology Neurosurgery and Psychiatry

Volumn 69, Issue 3, 2000, Pages 308-312

  Schrag, Anette ^a   Jahanshahi, Marjan ^a   Quinn, Niall ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Parkinson's disease; Quality of life

Indexed keywords

ADULT; AGED; AKINESIA; ARTICLE; BODY POSTURE; COGNITIVE DEFECT; CORRELATION FUNCTION; DEPRESSION; DISABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; TREMOR;

AGED; COGNITION DISORDERS; DEPRESSIVE DISORDER; DISABLED PERSONS; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PARKINSON DISEASE; POSTURE; QUALITY OF LIFE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY;

EID: 0033875826     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.69.3.308     Document Type: Article

References (30)

1. Lang AE, Lozano AM. Parkinson's disease. Second of two parts. N Engl J Med 1998;339:1130-43.
2. Peto V, Jenkinson C, Fitzpatrick R, et al. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995;4:241-8.
3. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998;245(suppl 1):S10-4.
4. Fitzpatrick R, Peto V, Jenkinson C, et al. Health-related quality of life in Parkinson's disease: a study of outpatient clinic attenders. Mov Disord 1997;12:916-22.
5. Fitzpatrick R, Jenkinson C, Peto V, et al. Desirable properties for instruments assessing quality of life: evidence from the PDQ-39. J Neurol Neurosurg Psychiatry 1997;62: 104.
6. Jenkinson C, Fitzpatrick R, Peto V, et al. The Parkinson's disease questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997;26:353-7.
7. Schrag A, Ben-Shlomo Y, Quinn NP. The population prevalence of atypical parkinsonian disorders. Lancet 1999;354: 1771-5.
8. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51;745-52.
9. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
10. Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson IML, eds. Third Symposium on Surgery in Parkinson's disease. Edinburgh: Livingstone, 1969:152-7.
11. Fahn S, Elton RL, members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, et al, eds. Recent developments in Parkinson's disease. Vol 2. Florham Park, NJ: MacMillan Healthcare Information, 1987:153-63.
12. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
13. Beck AT, Ward C, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-7.
14. EuroQoL Group. EuroQoL: a new facility for the measurement of health-related quality of life. Health Policy 1990;16: 199-208.
15. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
16. Jahanshahi M, Marsden CD. Depression in torticollis: a controlled study. Psychol Med 1988;18:925-33.
17. Jenkinson C, Fitzpatrick R, Peto V. The Parkinson's disease questionnaire. User manual for the PDQ-39, PDQ-8 and PDQ summary index. Oxford: Joshua Horgan Print Partnership, 1998.
18. Office of Population Censuses and Surveys. Classification of occupations and coding index, 1980. London: The Stationery Office, 1980.
19. Martinez-Martin P, Frades Payo B. Quality of life in Parkinson's disease: validation study of the PDQ-39 Spanish version. The Grupo Centro for Study of Movement Disorders. J Neurol 1998;(suppl 1):S34-8.
20. Findley L, Global Parkinson's Disease Steering Committee. Investigating factors which may influence quality of life in Parkinson's disease. Parkinsonism and Related Disorders 1999;5(suppl):146.
21. King RB. Quality of life after stroke. Stroke 1996;27:1467-72.
22. Livingston G, Watkin V, Milne B, et al. The natural history of depression and the anxiety disorders in older people: the Islington community study. J Affect Disord 1997;46:255-62.
23. Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993;43:2227-9.
24. Karlsen KH, Larsen JP, Tandberg E, et al. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;66:431-5.
25. Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 1985;35:522-6.
26. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990;40:1529-34.
27. Richards M, Marder K, Cote L, et al. Reliability of symptom onset assessment in Parkinson's disease. Mov Disord 1994; 9:340-2.
28. Block G, Liss C, Reines S, et al. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group. Eur Neurol 1997;37:23-7.
29. Williams LS, Weinberger M, Harris LE, et al. Measuring quality of life in a way that is meaningful to stroke patients. Neurology 1999;53:1839-43.
30. Brazier JE, Walters SJ, Nicholl JP, et al. Using the SF-36 and Euroqol on an elderly population. Qual Life Res 1996;5: 195-204.